CLINICAL_TRIALS
trial_result
· 2017-05-03
Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection [Phase 3]
Summary
Phase 3 trial update for the fixed-dose combination Sofosbuvir/Velpatasvir in adults with chronic hepatitis C virus infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 3 | Status: COMPLETED | Results posted: 2017-05-03